TransMedics Group, Inc. TMDX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about TransMedics Group, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TransMedics Group, Inc.'s stock issuance proceeds?
- TransMedics Group, Inc. (TMDX) reported stock issuance proceeds of $2.21M in Q1 2026.
- How has TransMedics Group, Inc.'s stock issuance proceeds changed year-over-year?
- TransMedics Group, Inc.'s stock issuance proceeds increased by 27.0% year-over-year, from $1.74M to $2.21M.
- What is the long-term trend for TransMedics Group, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), TransMedics Group, Inc.'s stock issuance proceeds has grown at a 93.8% compound annual growth rate (CAGR), from $974K to $13.75M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.